Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,064 Hematology
clinical trials

Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Florida Health Science Center ?? Gainesville
mi
from
Gainesville, FL
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Alliance for Childhood Diseases/Cure 4 the Kids Foundation
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Paroxysmal Nocturnal Hemoglobinuria (PNH) Clinical Trial
Extension Study of RA101495 for Patients With PNH Who Have Completed a RA101495 Clinical Study
Status: Enrolling, Phase II
Updated: 2/22/2018
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
Status: Enrolling, Phase IV
Updated: 12/31/1969
TRIO - Comprehensive Cancer Centers of Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Norton Children's Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Acute Myeloid Leukemia (AML) Clinical Trial
A Study of Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Gundersen Health System /ID# 164272
mi
from
La Crosse, WI
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of bb21217 in Multiple Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
Winship Cancer Insitute, Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Acute Myeloid Leukaemia Clinical Trial
Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Patients.
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Endocrinology, Hematology Clinical Trial
Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia
Status: Enrolling, Phase II
Updated: 12/31/1969
Spruce Biosciences Clinical Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Endocrinology, Hematology Clinical Trial
Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia
Status: Enrolling, Phase II
Updated: 12/31/1969
Spruce Biosciences Clinical Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of AZD5991 in Relapsed or Refractory Haematologic Malignancies.
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of AZD5991 in Relapsed or Refractory Haematologic Malignancies.
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Hemophilia A, Congenital Clinical Trial
Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis
Status: Enrolling, Phase
Updated: 12/31/1969
Washington University Center for Bleeding and Blood Clotting Disorders
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Advocate Lutheran General Hospital Oncology Specialists, S.C.
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Pittsburgh Medical Center (UPMC) - Hillman Cancer Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Massachusetts Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Status: Enrolling, Phase III
Updated: 12/31/1969
Incyte Investigative Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Status: Enrolling, Phase III
Updated: 12/31/1969
Incyte Investigative Site
mi
from
Lexington, KY
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Status: Enrolling, Phase III
Updated: 12/31/1969
Incyte Investigative Site
mi
from
Omaha, NE
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Status: Enrolling, Phase III
Updated: 12/31/1969
Incyte Investigative Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Status: Enrolling, Phase III
Updated: 12/31/1969
Incyte Investigative Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Status: Enrolling, Phase III
Updated: 12/31/1969
Incyte Investigative Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML).
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Virginia Cancer Specialists - Fairfax Office
mi
from
Fairfax, VA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Safety and Efficacy Study to Evaluate Luspatercept in Subjects With Myeloproliferative Neoplasm-associated Myelofibrosis Who Have Anemia With and Without Red Blood Cell-transfusion Dependence
Status: Enrolling, Phase II
Updated: 12/31/1969
Mid Florida Hematology and Oncology Centers
mi
from
Orange City, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
Children's Hospital Colorado /ID# 161551
mi
from
Aurora, CO
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Oncology (James Casey) - USOR
mi
from
Austin, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Oncology and Hematology Associates of Southwest Virginia (Blacksburg) - USOR
mi
from
Blacksburg, VA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Rocky Mountain Cancer Centers (Williams) - USOR
mi
from
Denver, CO
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
SCRI Tennessee Oncology - Summit
mi
from
Hermitage, TN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Mayo Clinic Jacksonville - PPDS
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
SCRI Florida Cancer Specialists North
mi
from
Largo, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Baptist Health System (N Kendall) - USOR
mi
from
Miami, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
SCRI Florida Cancer Specialists North
mi
from
Spring Hill, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Rocky Mountain Cancer Centers (Thornton) - USOR
mi
from
Thornton, CO
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Arizona Oncology Associates (Orange HOPE) - USOR
mi
from
Tucson, AZ
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Michigan, Pediatric Hematology and Oncology
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
St. Joseph's Children's Hospital, Center for Bleeding and Clotting Disorders
mi
from
Tampa, FL
Click here to add this to my saved trials
Beta-Thalassemia Clinical Trial
A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Subjects With Transfusion-Dependent β-Thalassemia, Who do Not Have a β0/β0 Genotype
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Chronic Phase Chronic Myeloid Leukemia Clinical Trial
Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States
Status: Enrolling, Phase
Updated: 12/31/1969
Frontier Cancer Center
mi
from
Billings, MT
Click here to add this to my saved trials
Chronic Phase Chronic Myeloid Leukemia Clinical Trial
Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States
Status: Enrolling, Phase
Updated: 12/31/1969
Stony Brook Cancer Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Benign Prostatic Hyperplasia Clinical Trial
Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)
Status: Enrolling, Phase II
Updated: 4/23/2018
Advanced Clinical Research - Boise
mi
from
Meridian, ID
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trial Site
mi
from
Melbourne,
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Safety and Dose Escalation Study of an Adeno-Associated Viral Vector for Gene Transfer in Hemophilia A Subjects
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Gulf States Hemophilia and Thrombophilia Center City
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of ACTR087 in Combination With SEA-BCMA in Subjects With Relapsed or Refractory Multiple Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
Indiana Bone and Marrow Transplantation
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder Clinical Trial
Tabelecleucel for Solid Organ Transplant Subjects With EBV+ PTLD After Failure of Rituximab or Rituximab and Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Montefiore Medical Center (Adults only)
mi
from
Bronx, NY
Click here to add this to my saved trials
Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder Clinical Trial
Tabelecleucel for Solid Organ Transplant Subjects With EBV+ PTLD After Failure of Rituximab or Rituximab and Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Washington University School of Medicine (Adults only)
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hereditary Hemochromatosis Clinical Trial
A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
East Setauket, NY
Click here to add this to my saved trials
Hereditary Hemochromatosis Clinical Trial
A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Hereditary Hemochromatosis Clinical Trial
A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Hereditary Hemochromatosis Clinical Trial
A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
North Little Rock, AR
Click here to add this to my saved trials
Hereditary Hemochromatosis Clinical Trial
A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Hereditary Hemochromatosis Clinical Trial
A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Amyloidosis, Hereditary Clinical Trial
ATTR Expanded Access Program (EAP) by Ionis
Status: Enrolling, Phase
Updated: 12/31/1969
Oregon Health and Science University, Knight Cardiovascular Institute
mi
from
Portland, OR
Click here to add this to my saved trials
Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder Clinical Trial
Tabelecleucel for Allogeneic Hematopoietic Cell Transplant Subjects With EBV+ PTLD After Failure of Rituximab
Status: Enrolling, Phase III
Updated: 12/31/1969
UNC Hospitals (Adults and Pediatrics)
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder Clinical Trial
Tabelecleucel for Allogeneic Hematopoietic Cell Transplant Subjects With EBV+ PTLD After Failure of Rituximab
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Miami Leonard M. Miller School of Medicine - Miami Transplant Institute (Adults only)
mi
from
Miami, FL
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients at a Dose of 4E13 vg/kg
Status: Enrolling, Phase III
Updated: 12/31/1969
Michigan State University Center for Bleeding and Clotting Disorders
mi
from
East Lansing, MI
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients at a Dose of 4E13 vg/kg
Status: Enrolling, Phase III
Updated: 12/31/1969
Washington University School of Medicine, Department of Pediatrics, Division of Hematology/Oncology
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hematology, Orthopedics / Podiatry Clinical Trial
Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease
Status: Enrolling, Phase I
Updated: 12/31/1969
North Carolina Cancer Hospital
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Gene Therapy for Haemophilia A.
Status: Enrolling, Phase I
Updated: 2/19/2018
Royal Free Hospital
mi
from
London,
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making
Status: Enrolling, Phase
Updated: 12/31/1969
Joel Epstein
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making
Status: Enrolling, Phase
Updated: 12/31/1969
Eastern Carolina University School of Dental Medicine
mi
from
Greenville, NC
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making
Status: Enrolling, Phase
Updated: 12/31/1969
Chrysalis Clinical Research
mi
from
Saint George, UT
Click here to add this to my saved trials
Leukemia, Myeloid, Acute Clinical Trial
Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Southwest Cancer Center
mi
from
Lubbock, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Safety, PK and Efficacy Study of CC-92480 in Combination With Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
Tom Baker Cancer Center
mi
from
Calgary,
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
A Study of IMR-687 in Adult Patients With Sickle Cell Anaemia (Homozygous HbSS or Sickle-β0 Thalassemia)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Connecticut Health Center (UConn Health)
mi
from
Farmington, CT
Click here to add this to my saved trials
Chronic Graft Versus Host Disease cGVHD Clinical Trial
Safety and Efficacy of AMG 592 in Subjects With Steroid Refractory Chronic Graft Versus Host Disease
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Duarte, CA
Click here to add this to my saved trials
Chronic Graft Versus Host Disease cGVHD Clinical Trial
Safety and Efficacy of AMG 592 in Subjects With Steroid Refractory Chronic Graft Versus Host Disease
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Leuven,
Click here to add this to my saved trials
Hematology Clinical Trial
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency as Open Label Extension
Status: Enrolling, Phase III
Updated: 4/19/2018
Children's of Alabama (CoA)
mi
from
Birmingham, AL
Click here to add this to my saved trials
Hematology Clinical Trial
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency as Open Label Extension
Status: Enrolling, Phase III
Updated: 4/19/2018
CHU Sainte-Justine
mi
from
Montréal,
Click here to add this to my saved trials
Leukemia, Myeloid, Acute Clinical Trial
A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
M.D. Anderson Cancer Center; Department of Hematology
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Orthopedics / Podiatry Clinical Trial
An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD)
Status: Enrolling, Phase II
Updated: 12/31/1969
UZ Leuven
mi
from
Leuven,
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Alabama at Birmingham - Nephrology Research Clinic
mi
from
Birmingham, AL
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Lysosomal and Rare Disorders Research and Treatment Center
mi
from
Fairfax, VA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Short Course Daratumumab in Patients With Multiple Myeloma
Status: Enrolling, Phase II
Updated: 12/31/1969
Memoral Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Short Course Daratumumab in Patients With Multiple Myeloma
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering @ Rockville
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Ascorbic Acid Levels in MDS, AML, and CMML Patients
Status: Enrolling, Phase
Updated: 12/31/1969
Metro Health - University of Michigan Health
mi
from
Wyoming, MI
Click here to add this to my saved trials
Hematology Clinical Trial
A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology Clinical Trial
A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Iowa City, IA
Click here to add this to my saved trials
Hematology Clinical Trial
A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Norfolk, VA
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Extension Study of 1 mg/kg Pegunigalsidase Alfa in Patients With Fabry Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
UAB Medicine
mi
from
Birmingham, AL
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Montreal,
Click here to add this to my saved trials
Hemophilia B Clinical Trial
HOPE-B: Trial of AMT-061 in Severe or Moderately Severe Hemophilia B Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
Hemophilia Center of Western New York
mi
from
Buffalo, NY
Click here to add this to my saved trials
Hemophilia B Clinical Trial
HOPE-B: Trial of AMT-061 in Severe or Moderately Severe Hemophilia B Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
Los Angeles Orthopedic Hospital
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hemophilia A or B Clinical Trial
PF-06741086 Long-term Treatment in Severe Hemophilia
Status: Enrolling, Phase II
Updated: 12/31/1969
UC Denver Hemophilia and Thrombosis Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Bergen
mi
from
Montvale, NJ
Click here to add this to my saved trials
AL Amyloidosis Clinical Trial
Ixazomib Maintenance Study in Patients With AL Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Memoral Sloan Kettering Basking Ridge
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
AL Amyloidosis Clinical Trial
Ixazomib Maintenance Study in Patients With AL Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Commack
mi
from
Commack, NY
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 7: Hemophilia Natural History Study
Status: Enrolling, Phase
Updated: 12/31/1969
Boston Hemophilia Center at Children's Hospital of Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 7: Hemophilia Natural History Study
Status: Enrolling, Phase
Updated: 12/31/1969
Pennsylvania Comprehensive Hemophilia and Thrombophilia Program / Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 7: Hemophilia Natural History Study
Status: Enrolling, Phase
Updated: 12/31/1969
UCSF Pediatric Hemophilia Treatment Center at Mission Bay
mi
from
San Francisco, CA
Click here to add this to my saved trials
Relapsed/ Refractory Multiple Myeloma Clinical Trial
Study Evaluating AMG 424 in Subjects With Multiple Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling, Phase
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling, Phase
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Clinical Benefit of SAR650984, Bortezomib, Lenalidomide and Dexamethasone Combination in NDMM Patients Not Eligible for Transplant
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Billings, MT
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Clinical Benefit of SAR650984, Bortezomib, Lenalidomide and Dexamethasone Combination in NDMM Patients Not Eligible for Transplant
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Clinical Benefit of SAR650984, Bortezomib, Lenalidomide and Dexamethasone Combination in NDMM Patients Not Eligible for Transplant
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Doctors Park
mi
from
East China Township, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
PeaceHealth Saint John Medical Center
mi
from
Longview, WA
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Mary's Oncology/Hematology Associates of Marlette
mi
from
Marlette, MI
Click here to add this to my saved trials
1 … 112 113 114 115 116 117 118 119 120 121